Overview
Protheragen-ING supplies active pharmaceutical ingredients (APIs) for anti-tumor, hypoglycemic, antipsychotic, bronchiectasis, and antihypertensive applications, alongside pharmaceutical excipients, intermediates, and veterinary products. It offers AI-powered drug discovery services including target identification, candidate optimization, drug repositioning, high-throughput screening, and AI synthesizers for small molecules and antibody drug conjugates. Additionally, Protheragen-ING Lab provides GLP-compliant lab synthesis, testing, medical device safety, biocompatibility, and validation services for pharmaceutical and biotech industries.
Frequently asked questions
- What APIs does Protheragen-ING supply?
- Protheragen-ING supplies hundreds of APIs including anti-tumor (e.g., enzalutamide, olaparib), hypoglycemic, antipsychotic for schizophrenia and bipolar, bronchiectasis (e.g., umeclidinium bromide), and antihypertensive APIs like ACE inhibitors and beta blockers.
- What AI drug discovery capabilities does Protheragen-ING offer?
- Protheragen-ING provides AI-powered services for target identification, drug candidate screening and optimization, drug repositioning/repurposing, high-throughput screening, and AI synthesizers for small molecule drugs and antibody drug conjugates.
- What regulatory-compliant services does Protheragen-ING Lab provide?
- Protheragen-ING Lab, a GLP service provider, offers medical device safety testing, biocompatibility testing, validation/verification, reusable device testing, lab synthesis, and drug analysis services to meet regulatory requirements.